Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...

TRIMTECH Therapeutics’s incredible $31million seed funding haul will be deployed to develop treatments for severe ...

With the involvement of around 30 specialist practices across Germany, DZNE will investigate whether dedicated memory tests on smartphones can help to detect mild cognitive impairment (MCI) at an ...